Phthalimide–benzoic acid hybrids as potent aldose reductase inhibitors: Synthesis, enzymatic kinetics, and in silico characterization
 
Yazarlar (7)
Dafina Hoti
Arleta Rifati Nixha
Doç. Dr. Hatice Esra DURAN Kafkas Üniversitesi, Türkiye
Prof. Dr. Mustafa Arslan Sakarya Üniversitesi, Türkiye
Prof. Dr. Cüneyt Türkeş Erzincan Binali Yıldırım Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı BIOORGANIC & MEDICINAL CHEMISTRY (Q1)
Dergi ISSN 0968-0896 Dergi Bilgileri (2025)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 12-2025
Cilt / Sayı / Sayfa 131 / 0 / 118416–0 DOI 10.1016/j.bmc.2025.118416
Makale Linki https://doi.org/10.1016/j.bmc.2025.118416
UAK Araştırma Alanları
Tıbbi Biyokimya
Özet
Aldose reductase (ALR2; AKR1B1) is implicated in hyperglycemia-driven tissue injury and remains a tractable enzymatic target. We developed a concise, chromatography-free two-step route to phthalimide–benzoic acid hybrids (5a–5m) and profiled their biochemical activity against human ALR2. Across the series, halogenated analogs were most active, with the para-bromophenyl derivative 5d emerging as the top hit (KI = 7.56 nM). Steady-state kinetic analysis indicated a competitive inhibition mechanism. Molecular docking to the ALR2 active site (PDB 4JIR), supported by MM-GBSA rescoring, yielded a catalytically consistent binding mode featuring hydrogen-bonding within the anion-binding region (Tyr48, His110) and complementary hydrophobic contacts (Trp111, Trp219), with Cys298 contributing as a proximal hydrophobic contact. In cell-based assays (A549, Hep3B, L929), the compounds generally …
Anahtar Kelimeler
Phthalimide-benzoic acid hybrids | Structure-activity relationship (SAR) | Enzyme kinetics (competitive inhibition) | Molecular docking | MM-GBSA binding energy | ADME/Tox prediction | Diabetic complications / polyol pathway
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 45
Google Scholar 50
Phthalimide–benzoic acid hybrids as potent aldose reductase inhibitors: Synthesis, enzymatic kinetics, and in silico characterization

Paylaş